A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale.
暂无分享，去创建一个
F. Mazzoni | A. Ardizzoni | M. Tiseo | C. Ficorella | A. Bonetti | C. Genova | F. Barbieri | G. Pasello | S. Cinieri | F. Artioli | A. Follador | K. Rihawi | M. Tognetto | A. Frassoldati | F. Riccardi | I. Colantonio | F. Gelsomino | G. Lamberti | M. Brighenti | E. Andrini | Elisa Andrini